Osteosarcoma tissue exhibits reduced levels of CLDN2 expression, thereby inhibiting the Ras/Raf/MEK/ERK signaling pathway via afadin and eventually reducing the capacity of osteosarcoma cells to migrate (29). The gene discussed is CLDN2; the disease is osteosarcoma.